Business Acquisition Consol Pro Forma operating results assuming begin of prior year as acq date (Details) (MTS-Medication Technologies [Member], USD $) In Thousands, unless otherwise specified	3 Months Ended
Sep. 30, 2012	Sep. 30, 2011
MTS-Medication Technologies [Member]
Business Acquisition [Line Items]
Revenues	$ 342,770	$ 320,771
Net income	$ 19,030	$ 14,842

The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-Subparagraph (h)(2)-(3)

-URI http://asc.fasb.org/extlink&oid=7659399&loc=d3e1392-128463

Name:	us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration